Sara Nik
Stock Analyst at HC Wainwright & Co.
(n/a)
# 4,939
Out of 5,172 analysts
5
Total ratings
n/a
Success rate
-62.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sara Nik
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRIS Curis | Reiterates: Buy | $17 | $0.77 | +2,104.36% | 1 | Mar 20, 2026 | |
| MBRX Moleculin Biotech | Maintains: Buy | $4 → $22 | $2.06 | +967.96% | 3 | Dec 11, 2025 | |
| KTTA Pasithea Therapeutics | Initiates: Buy | $3 | $0.80 | +276.41% | 1 | Dec 8, 2025 |
Curis
Mar 20, 2026
Reiterates: Buy
Price Target: $17
Current: $0.77
Upside: +2,104.36%
Moleculin Biotech
Dec 11, 2025
Maintains: Buy
Price Target: $4 → $22
Current: $2.06
Upside: +967.96%
Pasithea Therapeutics
Dec 8, 2025
Initiates: Buy
Price Target: $3
Current: $0.80
Upside: +276.41%